Investors focused on the Medical space have likely heard of Anthem , but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.

Anthem is one of 845 individual stocks in the Medical sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ANTM is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for ANTM's full-year earnings has moved 1.14% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

According to our latest data, ANTM has moved about 25.63% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 2.99% on average. This shows that Anthem is outperforming its peers so far this year.

To break things down more, ANTM belongs to the Medical - HMOs industry, a group that includes 13 individual companies and currently sits at #58 in the Zacks Industry Rank. On average, this group has gained an average of 24.48% so far this year, meaning that ANTM is performing better in terms of year-to-date returns.

Investors with an interest in Medical stocks should continue to track ANTM. The stock will be looking to continue its solid performance.